Login Register Cart 0
Generic placeholder image

Current Traditional Medicine

Editor-in-Chief

ISSN (Print): 2215-0838
ISSN (Online): 2215-0846

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

A Comprehensive Review on Chemistry and Contribution of Chinese Herb Epimedium brevicornum Maxim in Medicine

Author(s): Neetu Agrawal*, Deepika Goyal and Dimple Bansal

Volume 10, Issue 4, 2024

Published on: 22 June, 2023

Article ID: e070623217764 Pages: 13

DOI: 10.2174/2215083810666230607151656

Price: $65

Abstract

Background: Traditional Chinese medicine (TCM) is a complete medical system that has been used for more than 2,000 years and it is effective to use Epimedium Brevicornum (EB) Maxim, one of the Chinese herbs belonging to the family Berberidaceae is of major use because of its bioactive compound Icariin (ICA).

Objective: This review aims on providing a collective report of the description, taxonomy, therapeutic uses, bioactive compounds, and the different pharmacological activities of the plant EB for future research.

Methods: Data was obtained from various informative tools like PubMed, ScienceDirect, Google Scholar, and the botanical information sites for different plants.

Results: This literature review shows that the Chinese herb EB possesses various therapeutic effects and can be used in the prophylaxis of different ailments. The extract of different parts of EB contains many bioactive compounds such as phenols, flavonoids, and lignans. They show a wide range of pharmacological activities which include anti-inflammatory, anti-infertility, anti-cancer, and effective against Alzheimer’s disease and osteoporosis. ICA was found to be the major constituent of this herbal plant aiding in almost every pharmacological activity.

Conclusion: The review covers every activity the plant holds and indicates that the plant is a useful source in eradicating a variety of ailments. Researchers have performed invitro and invivo experiments to explore plant capabilities. The plant could be of very much use in botanical and pharmacological fields. For experts aiming to research EB, this review could be a great source of information.

Graphical Abstract

[1]
Zhang ZY, Li C, Zug C, Schluesener HJ. Icariin ameliorates neuropathological changes, tgf-b1 accumulation and behavioral deficits in a mouse model of cerebral amyloidosis. PLoS One 2014; 9(8): e104616.
[http://dx.doi.org/10.1371/journal.pone.0104616] [PMID: 25101849]
[2]
Zhang Y, Li J, Wang Y, Liang Q. Taxonomy of Epimedium (Berberidaceae) with special reference to Chinese species. Chin Herb Med 2022; 14(1): 20-35.
[http://dx.doi.org/10.1016/j.chmed.2021.12.001] [PMID: 36120133]
[3]
Shen P, Guo BL, Gong Y, Hong DYQ, Hong Y, Yong EL. Taxonomic, genetic, chemical and estrogenic characteristics of Epimedium species. Phytochemistry 2007; 68(10): 1448-58.
[http://dx.doi.org/10.1016/j.phytochem.2007.03.001] [PMID: 17434191]
[4]
Epimedium brevicornu. Available from: https://www.missouribotanicalgarden.org/PlantFinder/PlantFinderDetails.aspx?taxonid=291483&isprofile=1&gen=Epimedium
[5]
Li LR, Sethi G, Zhang X, et al. The neuroprotective effects of icariin on ageing, various neurological, neuropsychiatric disorders, and brain injury induced by radiation exposure. Aging (Albany NY) 2022; 14(3): 1562-88.
[http://dx.doi.org/10.18632/aging.203893] [PMID: 35165207]
[6]
Mahboubi M. Epimedium brevicornumMaxim and its efficacy in the treatment of sexual dysfunction. Nat Prod J 2021; 11(4): 438-47.
[http://dx.doi.org/10.2174/2210315510999200511133334]
[7]
He J, Li X, Wang Z, et al. Therapeutic anabolic and anticatabolic benefits of natural chinese medicines for the treatment of osteoporosis. Front Pharmacol 2019; 10: 1344.
[http://dx.doi.org/10.3389/fphar.2019.01344] [PMID: 31824310]
[8]
Chunmei W, Yunxiang L, Qiumei Q, Ran Z, Qiang G. Relationship between fruit maturity and habitats of Epimedium brevicornum. Chin J Appl Environ Biol 2008; 14: 187-91.
[9]
Li P, Fan J, Song C, Dong X, Kang D. Seed vigour and morphological and physiological characteristics of Epimedium brevicornu Maxim: In different stages of seed development. Plants 2022; 11(18): 2399.
[http://dx.doi.org/10.3390/plants11182399] [PMID: 36145800]
[10]
Zhang H, Wang H, Wei J, et al. Comparison of the active compositions between raw and processed Epimedium from different species. Molecules 2018; 23(7): 1656.
[http://dx.doi.org/10.3390/molecules23071656] [PMID: 29986486]
[11]
De Naeyer A, Pocock V, Milligan S, De Keukeleire D. Estrogenic activity of a polyphenolic extract of the leaves of Epimedium brevicornum. Fitoterapia 2005; 76(1): 35-40.
[http://dx.doi.org/10.1016/j.fitote.2004.10.002] [PMID: 15664460]
[12]
Li J, Luo M, Wang S, et al. Icariin ameliorates lower back pain in rats via suppressing the secretion of cytokine-induced neutrophil chemoatractant-1. BioMed Res Int 2020; 2020: 4670604.
[http://dx.doi.org/10.1155/2020/4670604] [PMID: 32802846]
[13]
Abdelaziz AS, Kamel MA, Ahmed AI, et al. Chemotherapeutic Potential of Epimedium brevicornum Extract: The cGMP-Specific PDE5 inhibitor as anti-infertility agent following long-term administration of tramadol in male rats. Antibiotics (Basel) 2020; 9(6): 318.
[http://dx.doi.org/10.3390/antibiotics9060318] [PMID: 32545153]
[14]
Gao B, Yu J, Xiao P. Chemical constituents from the aerial part of Epimedium brevicornum Maxim. Zhongguo Zhongyao Zazhi 1996; 21(5): 290-2319.
[PMID: 9388935]
[15]
Zhang G, Qin L, Hung WY, et al. Flavonoids derived from herbal Epimedium brevicornum Maxim prevent OVX-induced osteoporosis in rats independent of its enhancement in intestinal calcium absorption. Bone 2006; 38(6): 818-25.
[http://dx.doi.org/10.1016/j.bone.2005.11.019] [PMID: 16413840]
[16]
Li HB, Chen F. Separation and purification of epimedin A, B, C, and icariin from the medicinal herb Epimedium brevicornum maxim by dual-mode HSCCC. J Chromatogr Sci 2009; 47(5): 337-40.
[http://dx.doi.org/10.1093/chromsci/47.5.337] [PMID: 19476698]
[17]
Chen KK, Chiu JH. Effect of Epimedium brevicornum Maxim extract on elicitation of penile erection in the rat. Urology 2006; 67(3): 631-5.
[http://dx.doi.org/10.1016/j.urology.2005.09.051] [PMID: 16527595]
[18]
Xu Y, Wang NY, Song XJ, et al. Discovery of novel N-(5-(tert-butyl)isoxazol-3-yl)-N′-phenylurea analogs as potent FLT3 inhibitors and evaluation of their activity against acute myeloid leukemia in vitro and in vivo. Bioorg Med Chem 2015; 23(15): 4333-43.
[http://dx.doi.org/10.1016/j.bmc.2015.06.033] [PMID: 26142317]
[19]
Hong-Li G, Min-Jie W, Jin Z, Shu-Jun Z, Jing-Shan S. Studies on chemical constituents of Epimedium brevicornum. Chung Kuo Yao Hsueh Tsa Chih 2006; 41: 1060-2.
[20]
Li Y-B, Meng F-H, Lu X-M, Li F-M. Chemical constituents from herb of Epimedium brevicornum. Zhongguo Zhongyao Zazhi 2005; 30(8): 586-8.
[PMID: 16011280]
[21]
Luo GJ, Ci XX, Ren R, et al. Isolation of two new prenylflavonols from Epimedium brevicornum and their effects on cytokine production in vitro. Planta Med 2009; 75(8): 843-7.
[http://dx.doi.org/10.1055/s-0029-1185376] [PMID: 19242901]
[22]
Li F, Du BW, Lu DF, et al. Flavonoid glycosides isolated from Epimedium brevicornum and their estrogen biosynthesis-promoting effects. Sci Rep 2017; 7(1): 7760.
[http://dx.doi.org/10.1038/s41598-017-08203-7] [PMID: 28798396]
[23]
Ren FC, Jiang XJ, Wen SZ, Wang LX, Li XM, Wang F. Prenylated 2-phenoxychromones and flavonoids from Epimedium brevicornum and revised structures of epimedonins A and B. J Nat Prod 2018; 81(1): 16-21.
[http://dx.doi.org/10.1021/acs.jnatprod.7b00514] [PMID: 29338226]
[24]
Guo BL, Li WK, Yu JG, Xiao PG. Brevicornin, a flavonol from Epimedium brevicornum. Phytochemistry 1996; 41(3): 991-2.
[http://dx.doi.org/10.1016/0031-9422(95)00715-6]
[25]
Shu-Jun Z, Guo H-L, Shu-Jun Z, Jing-Shan S. Chemical constituents of Epimedium brevicornum (II). Chin Tradit Herbal Drugs 2008; 39: 325-7.
[26]
Zhao Y, Hou Y, Tang G, et al. Optimization of ultrasonic extraction of phenolic compounds from epimedium brevicornum maxim using response surface methodology and evaluation of its antioxidant activities in vitro. J Anal Methods Chem 2014; 2014: 864654.
[http://dx.doi.org/10.1155/2014/864654] [PMID: 25478287]
[27]
Li HZ, Luo GJ, Li HM, Li XL, Li RT. A new aryltetrahydronaphthalene lignan from Epimedium brevicornum. Chin Chem Lett 2011; 22(1): 85-7.
[http://dx.doi.org/10.1016/j.cclet.2010.09.001]
[28]
Yang Y, Zhang H-J, Zhu Z-H, He H-H. Studies on the chemical constituents of Epimedium brevicornum. Zhong Yao Cai 2009; 32(7): 1051-3.
[PMID: 19873729]
[29]
Yuk SS, Lim EM, Lee JY, et al. Antiinflammatory effects of Epimedium brevicornum water extract on lipopolysaccharide-activated RAW264.7 macrophages. Phytother Res 2010; 24(12): 1781-7.
[http://dx.doi.org/10.1002/ptr.3161] [PMID: 20564498]
[30]
Ci X, Liang X, Luo G, et al. Regulation of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 cells by 2″-hydroxy-3″-en-anhydroicaritin involves down-regulation of NF-κB and MAPK expression. Int Immunopharmacol 2010; 10(9): 995-1002.
[http://dx.doi.org/10.1016/j.intimp.2010.04.015] [PMID: 20462523]
[31]
Sun X, Deng X, Cai W, et al. Icariin inhibits LPS-induced cell inflammatory response by promoting GRα nuclear translocation and upregulating GRα expression. Life Sci 2018; 195: 33-43.
[http://dx.doi.org/10.1016/j.lfs.2018.01.006] [PMID: 29317219]
[32]
Yang L, Lu D, Guo J, Meng X, Zhang G, Wang F. Icariin from Epimedium brevicornum Maxim promotes the biosynthesis of estrogen by aromatase (CYP19). J Ethnopharmacol 2013; 145(3): 715-21.
[http://dx.doi.org/10.1016/j.jep.2012.11.031] [PMID: 23261485]
[33]
Yap SP, Shen P, Li J, Lee LS, Yong EL. Molecular and pharmacodynamic properties of estrogenic extracts from the traditional Chinese medicinal herb, Epimedium. J Ethnopharmacol 2007; 113(2): 218-24.
[http://dx.doi.org/10.1016/j.jep.2007.05.029] [PMID: 17628368]
[34]
Fu X, Li S, Zhou S, Wu Q, Jin F, Shi J. Stimulatory effect of icariin on the proliferation of neural stem cells from rat hippocampus. BMC Complement Altern Med 2018; 18(1): 34.
[http://dx.doi.org/10.1186/s12906-018-2095-y] [PMID: 29378551]
[35]
Deng Y, Long L, Wang K, et al. Icariside II, a broad-spectrum anti-cancer agent, reverses beta-amyloid-induced cognitive impairment through reducing inflammation and apoptosis in rats. Front Pharmacol 2017; 8: 39.
[http://dx.doi.org/10.3389/fphar.2017.00039] [PMID: 28210222]
[36]
Liu S, Li X, Gao J, Liu Y, Shi J, Gong Q. Icariside II, a phosphodiesterase-5 inhibitor, attenuates beta-amyloid-induced cognitive deficits via BDNF/TrkB/CREB signaling. Cell Physiol Biochem 2018; 49(3): 1010-25.
[http://dx.doi.org/10.1159/000493232] [PMID: 30196289]
[37]
Li F, Dong HX, Gong QH, Wu Q, Jin F, Shi JS. Icariin decreases both app and aβ levels and increases neurogenesis in the brain of Tg2576 mice. Neuroscience 2015; 304: 29-35.
[http://dx.doi.org/10.1016/j.neuroscience.2015.06.010] [PMID: 26079110]
[38]
Li XA, Ho YS, Chen L, Hsiao WL. The protective effects of icariin against the homocysteine-induced neurotoxicity in the primary embryonic cultures of rat cortical neurons. Molecules 2016; 21(11): 1557.
[http://dx.doi.org/10.3390/molecules21111557] [PMID: 27879670]
[39]
Li F, Gong QH, Wu Q, Lu YF, Shi JS. Icariin isolated from Epimedium brevicornum Maxim attenuates learning and memory deficits induced by d-galactose in rats. Pharmacol Biochem Behav 2010; 96(3): 301-5.
[http://dx.doi.org/10.1016/j.pbb.2010.05.021] [PMID: 20566405]
[40]
Li WX, Deng YY, Li F, et al. Icariin, a major constituent of flavonoids from Epimedium brevicornum, protects against cognitive deficits induced by chronic brain hypoperfusion via its anti-amyloidogenic effect in rats. Pharmacol Biochem Behav 2015; 138: 40-8.
[http://dx.doi.org/10.1016/j.pbb.2015.09.001] [PMID: 26364923]
[41]
Gao J, Xu Y, Lei M, Shi J, Gong Q. Icariside II, a PDE5 inhibitor from Epimedium brevicornum, promotes neuron-like pheochromocytoma PC12 cell proliferation via activating NO/cGMP/PKG pathway. Neurochem Int 2018; 112: 18-26.
[http://dx.doi.org/10.1016/j.neuint.2017.10.015] [PMID: 29101001]
[42]
Zong N, Li F, Deng Y, Shi J, Jin F, Gong Q. Icariin, a major constituent from Epimedium brevicornum, attenuates ibotenic acid-induced excitotoxicity in rat hippocampus. Behav Brain Res 2016; 313: 111-9.
[http://dx.doi.org/10.1016/j.bbr.2016.06.055] [PMID: 27368415]
[43]
Meng FH, Li YB, Xiong ZL, Jiang ZM, Li FM. Osteoblastic proliferative activity of Epimedium brevicornum Maxim. Phytomedicine 2005; 12(3): 189-93.
[http://dx.doi.org/10.1016/j.phymed.2004.03.007] [PMID: 15830840]
[44]
Wei CC, Ping DQ, You FT, Qiang CY, Tao C. Icariin prevents cartilage and bone degradation in experimental models of arthritis. Mediators Inflamm 2016; 2016: 9529630.
[http://dx.doi.org/10.1155/2016/9529630] [PMID: 27199510]
[45]
Zheng H, He B, Wu T, Cai J, Wei J. Extraction, purification and anti-osteoporotic activity of a polysaccharide from Epimedium brevicornum Maxim. in vitro. Int J Biol Macromol 2020; 156: 1135-45.
[http://dx.doi.org/10.1016/j.ijbiomac.2019.11.145] [PMID: 31751710]
[46]
Gao J, Zhuang S, Wang Y, et al. Evaluation of <i>Epimedium brevicornum</i> Maxim extract for anti-osteoporosis activity in rats. Trop J Pharm Res 2017; 16(9): 2185.
[http://dx.doi.org/10.4314/tjpr.v16i9.20]
[47]
Yap SP, Shen P, Butler MS, Gong Y, Loy CJ, Yong EL. New estrogenic prenylflavone from Epimedium brevicornum inhibits the growth of breast cancer cells. Planta Med 2005; 71(2): 114-9.
[http://dx.doi.org/10.1055/s-2005-837776] [PMID: 15729618]
[48]
Li X, Shi G. Therapeutic effects and mechanism of ferulic acid and icariin in mammary gland hyperplasia model rats via regulation of the ERK pathway. Ann Transl Med 2021; 9(8): 666.
[http://dx.doi.org/10.21037/atm-21-656] [PMID: 33987364]
[49]
Wang D, Xu W, Chen X, et al. Icariin induces cell differentiation and cell cycle arrest in mouse melanoma B16 cells via Erk1/2-p38-JNK-dependent pathway. Oncotarget 2017; 8(59): 99504-13.
[http://dx.doi.org/10.18632/oncotarget.20118] [PMID: 29245919]
[50]
Sun YS, Thakur K, Hu F, Zhang JG, Wei ZJ, Icariside II. Icariside II inhibits tumorigenesis via inhibiting AKT/Cyclin E/CDK 2 pathway and activating mitochondria-dependent pathway. Pharmacol Res 2020; 152: 104616.
[http://dx.doi.org/10.1016/j.phrs.2019.104616] [PMID: 31883767]
[51]
Sun YS, Thakur K, Hu F, et al. Icariside II suppresses cervical cancer cell migration through JNK modulated matrix metalloproteinase-2/9 inhibition in vitro and in vivo. Biomed Pharmacother 2020; 125: 110013.
[http://dx.doi.org/10.1016/j.biopha.2020.110013] [PMID: 32092821]
[52]
Dell’Agli M, Galli GV, Dal Cero E, et al. Potent inhibition of human phosphodiesterase-5 by icariin derivatives. J Nat Prod 2008; 71(9): 1513-7.
[http://dx.doi.org/10.1021/np800049y] [PMID: 18778098]
[53]
Chiu J-H, Chen K-K, Chien T-M, et al. Epimedium brevicornum Maxim extract relaxes rabbit corpus cavernosum through multitargets on nitric oxide/cyclic guanosine monophosphate signaling pathway. Int J Impot Res 2006; 18(4): 335-42.
[http://dx.doi.org/10.1038/sj.ijir.3901437] [PMID: 16395327]
[54]
Han W-R, Chuang C-Y, Young S-T, Chen K-K, Lin J-H. The effect of Epimedium brevicornum maxim (Yin Yang Huo) extract on elicitation of penile erection, and its power spectral analysis in rats Proceedings of the 2007 6th International Special Topic Conference on Information Technology Applications in Biomedicine. 76-8.
[http://dx.doi.org/10.1109/ITAB.2007.4407348]
[55]
Song YH, Li BS, Chen XM, Cai H. Ethanol extract from Epimedium brevicornum attenuates left ventricular dysfunction and cardiac remodeling through down-regulating matrix metalloproteinase-2 and -9 activity and myocardial apoptosis in rats with congestive heart failure. Int J Mol Med 2008; 21(1): 117-24.
[http://dx.doi.org/10.3892/ijmm.21.1.117] [PMID: 18097624]
[56]
Zhang Q, Li H, Wang S, Liu M, Feng Y, Wang X. Icariin protects rat cardiac H9c2 cells from apoptosis by inhibiting endoplasmic reticulum stress. Int J Mol Sci 2013; 14(9): 17845-60.
[http://dx.doi.org/10.3390/ijms140917845] [PMID: 23999590]
[57]
Coenye T, Brackman G, Rigole P, et al. Eradication of Propionibacterium acnes biofilms by plant extracts and putative identification of icariin, resveratrol and salidroside as active compounds. Phytomedicine 2012; 19(5): 409-12.
[http://dx.doi.org/10.1016/j.phymed.2011.10.005] [PMID: 22305279]
[58]
Wang M, Wang L, Zhou Y, Feng X, Ye C, Wang C. Icariin attenuates renal fibrosis in chronic kidney disease by inhibiting interleukin‐1β/transforming growth factor‐β‐mediated activation of renal fibroblasts. Phytother Res 2021; 35(11): 6204-15.
[http://dx.doi.org/10.1002/ptr.7256] [PMID: 34426999]
[59]
Jin H, Zhou Y, Ye J, et al. Icariin improves glucocorticoid resistance in a murine model of asthma with depression associated with enhancement of GR expression and function. Planta Med 2022; 39(3): 262-72.
[http://dx.doi.org/10.1055/a-1902-4244] [PMID: 35850481]
[60]
Hu L, Liu F, Li L, et al. Effects of icariin on cell injury and glucocorticoid resistance in BEAS 2B cells exposed to cigarette smoke extract. Exp Ther Med 2020; 20(1): 283-92.
[http://dx.doi.org/10.3892/etm.2020.8702] [PMID: 32550884]
[61]
Pan Y, Zhang WY, Xia X, Kong LD. Effects of icariin on hypothalamic-pituitary-adrenal axis action and cytokine levels in stressed Sprague-Dawley rats. Biol Pharm Bull 2006; 29(12): 2399-403.
[http://dx.doi.org/10.1248/bpb.29.2399] [PMID: 17142971]
[62]
Pan Y, Kong LD, Li YC, Xia X, Kung HF, Jiang FX. Icariin from Epimedium brevicornum attenuates chronic mild stress-induced behavioral and neuroendocrinological alterations in male Wistar rats. Pharmacol Biochem Behav 2007; 87(1): 130-40.
[http://dx.doi.org/10.1016/j.pbb.2007.04.009] [PMID: 17509675]
[63]
Pan Y, Wang FM, Qiang LQ, Zhang DM, Kong LD. Icariin attenuates chronic mild stress-induced dysregulation of the LHPA stress circuit in rats. Psychoneuroendocrinology 2010; 35(2): 272-83.
[http://dx.doi.org/10.1016/j.psyneuen.2009.06.020] [PMID: 19631474]
[64]
Zhang W, Bai X, Zheng X, Xie X, Yuan Z. Icariin attenuates the enhanced prothrombotic state in atherosclerotic rabbits independently of its lipid-lowering effects. Planta Med 2013; 79(9): 731-6.
[http://dx.doi.org/10.1055/s-0032-1328551] [PMID: 23700112]
[65]
Hu Y, Liu K, Yan M, Zhang Y, Wang Y, Ren L. Effects and mechanisms of icariin on atherosclerosis. Int J Clin Exp Med 2015; 8(3): 3585-9.
[PMID: 26064253]
[66]
Hu Y, Li H, Liu K, Zhang Y, Ren L, Fan Z. Protective effects of icariin on human vascular endothelial cells induced by oxidized low-density lipoprotein via modulating caspase-3 and Bcl-2. Mol Med Rep 2018; 17(5): 6835-9.
[http://dx.doi.org/10.3892/mmr.2018.8717] [PMID: 29532884]
[67]
Hu Y, Sun B, Liu K, et al. Icariin attenuates high-cholesterol diet induced atherosclerosis in rats by inhibition of inflammatory response and p38 MAPK signaling pathway. Inflammation 2016; 39(1): 228-36.
[http://dx.doi.org/10.1007/s10753-015-0242-x] [PMID: 26307750]
[68]
Hu Y, Liu K, Yan M, Zhang Y, Wang Y, Ren L. Icariin inhibits oxidized low-density lipoprotein-induced proliferation of vascular smooth muscle cells by suppressing activation of extracellular signal-regulated kinase 1/2 and expression of proliferating cell nuclear antigen. Mol Med Rep 2016; 13(3): 2899-903.
[http://dx.doi.org/10.3892/mmr.2016.4813] [PMID: 26820466]
[69]
Hong C, Yang L, Zhang Y, Li Y, Wu H. Epimedium brevicornum Maxim. Extract exhibits pigmentation by melanin biosynthesis and melanosome biogenesis/transfer. Front Pharmacol 2022; 13: 963160.
[http://dx.doi.org/10.3389/fphar.2022.963160] [PMID: 36249817]
[70]
Wang B, Yan F, Cai L. Anti-fatigue properties of icariin from Epimedium brevicornum. Biomed Res 2014; 25: 297-302.

Rights & Permissions Print Cite
© 2025 Bentham Science Publishers | Privacy Policy